Document:

EX-10.1

 Exhibit 10.1 

HCA HEALTHCARE, INC. 

2021 SENIOR OFFICER PERFORMANCE EXCELLENCE PROGRAM 

Purpose and Administration of the Program 

The 2021 Senior Officer Performance Excellence Program (the “Program”) has been established by HCA Healthcare, Inc. (the “Company”) to
encourage outstanding performance from its senior officers. Awards under the Program shall be administered as “Performance-Based Awards” pursuant to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates
(the “2020 Plan”). Subject to applicable law, all designations, determinations, interpretations, and other decisions under or with respect to the Program or any award shall be within the sole discretion of the Compensation Committee of the
Board of Directors of HCA Healthcare, Inc., including any subcommittee formed pursuant to Section 3(a) of the 2020 Plan (the “Committee”), may be made at any time and shall be final, conclusive and binding upon all persons.
Designations, determinations, interpretations, and other decisions made by the Committee with respect to the Program or any Award, including but not limited to the application of the PEP Recoupment Policy, described herein, need not be uniform and
may be made selectively among Participants, whether or not such Participants are similarly situated. 
 Participation 

All officers of the Company who have been designated by the Company as “executive officers” of the Company during 2021 (the “Fiscal Year”)
are eligible to receive an award pursuant to the Program (each, a “Participant”). 
 Incentive Calculation and Payment of Awards 

Awards shall be calculated based on the financial results for the Fiscal Year and most recently available quality and care experience results and shall be paid
within two and one-half months following the end of the Fiscal Year. No awards will be paid to a Participant until the Chief Executive Officer has affirmed that the Participant’s behavior and actions
during the Fiscal Year were consistent with the Company’s stated mission and values, the Code of Conduct and other regulatory requirements. 
 The
Committee will make awards pursuant to the Program (each, an “Award”) as set forth on Schedule A hereto, on such terms as the Committee may prescribe based on the performance criteria set forth on Schedule A hereto and such
other factors as it may deem appropriate. The targets for the performance criteria shall be determined by the Committee, in its discretion. The Committee shall determine and certify whether and to what extent each performance or other goal has been
met prior to the payment of any Award hereunder. A Participant is required to remain employed with the Company through the end of the Fiscal Year in order to have a legally binding right to the Award. 

Awards pursuant to the Program will be paid solely in cash. 

Except as provided for in any employment agreement or as the Committee may otherwise determine in its sole and absolute discretion, termination of a
Participant’s employment prior to the end of the Fiscal Year will result in the forfeiture of the Award by the Participant, and no payments shall be made with respect thereto. 

 This Program is not a “qualified” plan for federal income tax purposes, and any payments are
subject to applicable tax withholding requirements. 
 Adjustments for Unusual or Nonrecurring Events 

In addition to any adjustments enumerated in the definition of the performance goals set forth on Schedule A hereto, the Committee is hereby authorized
to make adjustments in the terms and conditions of, and the criteria included in, awards in recognition of unusual or nonrecurring events affecting any Participant, the Company, or any subsidiary or affiliate, or the financial statements of the
Company or of any subsidiary or affiliate; in the event of changes in applicable laws, regulations or accounting principles; or in the event the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement
of the benefits or potential benefits intended to be made available under the Program. The Committee is also authorized to adjust performance targets or reduce awards to avoid unwarranted windfalls. 

PEP Recoupment Policy 
 The Company may recover any
incentive compensation awarded or paid pursuant to this Program based on (i) achievement of financial results that were subsequently the subject of a restatement due to material noncompliance with any financial reporting requirement under
either GAAP or the federal securities laws, other than as a result of changes to accounting rules and regulations, or (ii) a subsequent finding that the financial information or performance metrics used by the Committee to determine the amount
of the incentive compensation were materially inaccurate, in each case regardless of individual fault. In addition, the Company may recover any incentive compensation awarded or paid pursuant to this Program based on a Participant’s conduct
which is not in good faith and which materially disrupts, damages, impairs or interferes with the business of the Company and its affiliates. This PEP Recoupment Policy applies to any incentive compensation earned or paid to a Participant pursuant
to this Program. Subsequent changes in status, including retirement or termination of employment, do not affect the Company’s rights to recover compensation under this policy. The Committee will administer this policy and exercise its
discretion and business judgment in the fair application of this policy based on the facts and circumstances as it deems relevant in its sole discretion. More specifically, the Committee shall determine in its discretion any appropriate amounts to
recoup, the officers from whom such amounts shall be recouped (which need not be all officers who received the bonus compensation at issue) and the timing and form of recoupment; provided, that only compensation paid or settled within three years
prior to the Committee taking action under this PEP Recoupment Policy shall be subject to recoupment; provided further, that any recoupment pursuant to clause (i) or (ii) of the first sentence of this paragraph shall not exceed the portion of
any applicable bonus paid hereunder that is in excess of the amount of performance-based or incentive compensation that would have been paid or granted based on the actual, restated financial statements or actual level of the applicable financial or
performance metrics as determined by the Committee in its sole discretion. 

 For avoidance of doubt, the Company may set off the amounts of any such required recoupment against any
amounts otherwise owed by the Company to a Participant as determined by the Committee in its sole discretion, solely to the extent any such offset complies with the requirements of Section 409A of the Code and the guidance issued thereunder.

 If any restatement of the Company’s financial results indicates that the Company should have made higher performance-based payments than those
actually made under the Program for a period affected by the restatement, then the Committee shall have discretion, but not the obligation, to cause the Company to make appropriate incremental payments to affected Participants then-currently
employed by the Company. The Committee will determine, in its sole discretion, the amount, form and timing of any such incremental payments, which shall be no more than the difference between the amount of performance-based compensation that was
paid or awarded and the amount that would have been paid or granted based on the actual, restated financial statements. 
 No Right to Employment

 The grant of an award shall not be construed as giving a Participant the right to be retained in the employ of the Company or any subsidiary or
affiliate. 
 No Trust or Fund Created 
 Neither the
Program nor any award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any subsidiary or affiliate and a Participant or any other person. To the extent that any person
acquires a right to receive payments from the Company or any subsidiary or affiliate pursuant to an award, such right shall be no greater than the right of any unsecured general creditor of the Company or any subsidiary or affiliate. 

No Rights to Awards 
 No person shall have any claim to be
granted any award and there is no obligation for uniformity of treatment among Participants. The terms and conditions of awards, if any, need not be the same with respect to each Participant. The Company reserves the right to terminate the Program
at any time in the Company’s sole discretion. 
 Section 409A of the Internal Revenue Code 

This Program is intended to comply with Section 409A of the Code and will be interpreted in a manner intended to comply with Section 409A of the
Code. 
 Interpretation and Governing Law 
 This Program
shall be governed by and interpreted and construed in accordance with the internal laws of the State of Delaware, without reference to principles of conflicts or choices of laws. In the event the terms of this Program are inconsistent with the terms
of any written employment agreement between a Participant and the Company, the terms of such written employment agreement shall govern the Participant’s participation in the Program. Capitalized terms not otherwise defined herein shall have the
meanings ascribed to them in the 2020 Plan. 

 Schedule A 

2021 PEP Measures and Weightings 
  

											
	 	  	Target PEP
Opportunity1	 	EBITDA
Weight2	 	 	Quality
Weight3	 
	 	  	(% of base salary) 	 	 	 	 	 	 
	 CEO
	  	170%	 	 	80	% 	 	 	20	% 
	 EVP & CFO
	  	125%	 	 	80	% 	 	 	20	% 
	 Group Presidents
	  	85-110%	 	 	80	% 	 	 	20	% 
	 Other Participants
	  	50-75%	 	 	80	% 	 	 	20	% 

 1 PEP Opportunity: Target PEP Opportunities are
expressed as a percentage of base salary as approved by the Committee. Maximum PEP opportunity payouts shall not exceed 200% of the Target PEP Opportunity stated above for any Participant. 

2 EBITDA Weight: For the minimum acceptable (threshold) level of
performance with respect to the EBITDA measure, a Participant may receive 25% of the EBITDA-weighted portion of the Target PEP Opportunity. For target level of performance with respect to the EBITDA measure, a Participant may receive 100% of the
EBITDA-weighted portion of the Target PEP Opportunity. For the maximum level of performance with respect to the EBITDA measure, a Participant may receive 200% of the EBITDA-weighted portion of the Target PEP Opportunity. Payouts for performance
between the threshold and maximum levels of performance for Participants will be calculated by the Committee in its sole discretion using straight-line interpolation. 

The EBITDA weighted portion of the American Group and National Group Presidents’ PEP awards will be based 50% on Company EBITDA
performance and 50% on their respective Group’s EBITDA performance. 
 For the purposes of this calculation, EBITDA means earnings
before interest, income taxes, depreciation, amortization, net income attributable to noncontrolling interests, gains or losses on sales of facilities, gains or losses on extinguishment of debt, legal claim costs (benefits), asset or investment
impairment charges, restructuring charges, expenses for share-based compensation under ASC Topic 718, and any other gains or charges resulting from significant, unusual and/or nonrecurring events, as described in management’s discussion
and analysis of financial condition and results of operations appearing in the Company’s annual report for the Fiscal Year, as determined in good faith by the Board or the Committee in consultation with the CEO. In the event the Company
disposes of any facility during the Fiscal Year, the EBITDA target for such year shall be adjusted appropriately (based on the number of days during the year for which the facility was owned) to reflect the disposition. In the event the Company
acquires a facility during the Fiscal Year, the EBITDA attributable to such facility will not be included in the calculation of the Company’s EBITDA performance for the Fiscal Year. 

 3 Quality Weight: The Quality
Weight for each Participant is based on each of the following three quality categories: Healthcare-Associated Infections and Core Measures (30%), CHOIS Risk-Adjusted Indices (30%) and Care Experience (40%) (as defined below). 

For performance at or below the minimum acceptable (threshold) level of performance with respect to each individual quality metric, a
Participant will not receive a payout for that metric. For target level of performance with respect to each individual quality metric, a Participant may receive 100% of the quality-weighted portion of the PEP opportunity tied to that individual
quality metric. For maximum level of performance with respect to each quality metric, a Participant may receive 200% of the quality-weighted portion of the PEP opportunity tied to that individual metric. Payouts for quality performance between the
threshold and maximum levels of performance for each quality metric for Participants will be calculated by the Committee in its sole discretion using straight-line interpolation from 0 – 200%. 

In the event the Company’s actual EBITDA is less than 90% of the target level of EBITDA set by the Committee, there will be no payout
with respect to the quality-weighted portion of PEP opportunity. 
 Healthcare Associated Infections metrics are Central Line-Associated
Blood Stream Infection (CLABSI), Catheter-Associated Urinary Tract Infection (CAUTI), Surgical Site Infections (SSI), Methicillin Resistant Staphylococcus Aureus (MRSA) and Clostridium difficile (C. diff ) for the Centers for Medicare
and Medicaid Services (CMS) reportable patient populations as defined by the Centers for Disease Control and Prevention’s National Healthcare Safety Network (CDC – NHSN). The following inpatient core measure is also included: Sepsis Bundle
(SEP-1) as developed by The Joint Commission and the Centers for Medicare and Medicaid Services (CMS) and set forth in the Specifications Manual for National Hospital Inpatient Quality Measures. 

The Risk-Adjusted CHOIS Mortality and Complication Index Values are calculated for an all payer population using the IBM Watson Health
Risk-Adjusted Mortality and Complication models. The indices are calculated internally and published to the CHOIS application. 
 The Care
Experience metric for inpatients is the CMS Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) overall rating top box score (CMS defines the “top box” score for the overall rating question to be a response of nine or
ten on the CMS HCAHPS survey). The Care Experience metric for emergency room patients is the Press Ganey Emergency Room overall rating “top box” score (Press Ganey defines the top box score for the overall question to be a response of
Very Good on the Patient Experience Emergency Room survey). 
 In the event the applicable governmental agency adjusts any of the
definitions of the quality metrics set forth above during the performance period, appropriate adjustments shall be made to the targets, or results, or both, to properly account for such changes, in the Committee’s sole discretion. 

In the event the Company divests, acquires or opens new facilities during the measurement period, the divested, acquired or newly opened
facilities will be excluded for purposes of calculating the Company’s performance on the quality-weighted metrics. 
 The threshold,
target and maximum EBITDA performance levels and other goals shall be set by the Committee in its sole discretion.Exhibit 10.1

 

 

Supplement Agreement of Equity Transfer Agreement

  

 

 

by and among

 

 

 

Tianjin AnGaoMeng Construction Development
Co., Ltd.

  

 

and 

 

Li Bo, Ruan Shenghua and Zheng Yongsheng

 

 

 

April 6, 2021

 

     
 

     

    

 

Acquiror: Tianjin
AnGaoMeng Construction Development Co., Ltd. (“Party A” or the “Acquiror”)

Address: Floor
3, Shui Li Da Sha, Fuzhou Road, Tanggu, Binhai New Area, Tianjin

Legal Representative:
Li Zhenhua

Unified Social
Credit Code of Enterprise Legal Person:

Seller: Li Bo
(“Party B” or the “Seller B”)

Address: Room

Nationality:

ID No.:

Seller: Ruan Shenghua
(“Party C” or the “Seller C”)

Address:

Nationality:

ID No.:

Seller: Ruan Shenghua
(“Party D” or the “Seller D”)

Address:

Nationality:

ID No.:

(Party B, Party
C and Party D are collectively referred to as “Sellers”, Sellers and Acquiror are collectively referred to as “Parties”.)

 

     
 

     

    

Whereas:

		1.	Yushu Kingo City Real Estate Development Co., Ltd. (the “Subject Company”) is a company limited
by shares established and existing in the Administrative Bureau for Industry and Commerce of Yushu under the laws of China, with a registered
capital of RMB30,000,000. Established on December 18, 2013 with its domicile at the West Section of Xiangyang Road, Yushu, the current
legal representative of the Subject Company is Li Bo and its business scope is real estate development and property management;

		2.	Party A is a wholly-owned subsidiary of AGM Group Holdings, Inc. (“AGMH”), a NASDAQ listed company.
AGMH has 21,791,055 Class A ordinary shares as of the date of this Agreement.

		3.	The Parties signed the Letter of Intent of Equity Acquisition on February 21, 2019 (In the Letter of Intent,
Party A's name is "Shenzhen AnGaoMeng Financial Technology Service Co., Ltd." which has been renamed as "Tianjin AnGaoMeng
Construction Development Co., Ltd.") and afterwards entered into an Equity Transfer Agreement (the “Original Transfer Agreement”)
on which the parties agreed upon the transfer price and payment method. Party A has made advance payments in the amount of $4,937,663.72
(the “Advance Payments”) to respective Seller. 

		4.	The construction schedule of the Target Company has been delayed due to the COVID-19 of 2020, and it is expected
that the completion date will be postponed to the 30th date of June 2021.

Base on the above
situation, after friendly consultations conducted in accordance with the principles of equity and mutual benefit, the Parties agree to
reach the Supplement Agreement with respect to the equity transfer in accordance with the Company Law of the People's Republic of China
and other applicable laws and regulations.

		1.	Supplement Terms

		1.1	The Parties agree that, by October 31, 2021, if Party A decides to abandon the acquisition, the Sellers
will return the $4,937,663.72 Advance Payment of the Original Transfer Agreement to Party A and pay for an additional 10% interest of
project delay loss to Party A.

		1.2	All Parties agree that if Sellers are unable to return 100% of the Advance Payment plus interest to Party
A, the Sellers agree to transfer titles of its real properties to Party A. The real estate price will be calculated at 20% discount of
the market price.

		1.3	Party A and the Sellers further agree to conduct a new evaluation of the real estate assets in light of
COVID-19 after the completion of the audit and to enter into a supplement agreement based on such evaluation. In the new valuation, the
Advance Payment plus interest returned by the Sellers shall count towards the final purchase price.

 

     
 

     

    

 

		2.	Miscellaneous Provisions

		2.1	Positioning, Supplement and Modification of the Agreement

This Supplement Agreement
shall have the same legal effect as the Original Transfer Agreement. Any supplement, amendment, annotation or annex to this Supplement
Agreement shall be agreed in writing by all Parties and shall be binding only after being signed.

		2.2	Effectiveness

This Agreement shall
be formally signed and sealed by the legal representatives or their authorized representatives of each party, and shall come into force
from the date of signature and seal of each party.

		2.3	Copies

This Supplement Agreement
is made in 8 copies, each party holds 2, all of which have the same legal effect.

		2.4	Other Matters

Matters not covered
in this Supplement Agreement shall be settled through friendly negotiation.

(Signatures follow on next
page)

 

     
 

     

    

 

 

Party A: Tianjin AnGaoMeing Construction
Development Co., Ltd.

 

/s/ Li Zhenhua

/seal/ 

 

Authorized Representative: Li Zhenhua

 

Date: April 6, 2021

 

 

 

Party B or Party B’s Authorized
Representative: Li Bo

 

/s/ Li Bo

 

Date: April 6, 2021

 

Tel:

 

 

Party C or Party C’s Authorized
Representative: Ruan Shenghua

 

/s/ Ruansheng Hua

 

Date: April 6, 2021

 

Tel:

 

 

 

Party D or Party D’s Authorized
Representative: Zheng Yongsheng

 

/s/ Zheng Yongsheng

 

Date: April 6, 2021

 

Tel:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]